Monte Rosa Therapeutics, Inc. (GLUE) Insider Trading

Over the last 3 months, GLUE insiders made 0 open-market buys and 9 sales, a net sale of -$838K (SEC Form 4). Over the last 6 months, 147 institutions increased and 81 reduced their position (13F).

Insider Activity

Sentiment
0/100
Buys (3m)
0
Sells (3m)
9
Net (3m)
-$838.4K
Insider trades by month Buys Sells
Jan
Feb
Mar
Apr
May
Jun
Context3-month price -3.3%Institutions accumulating (13F)
DateInsiderTypeSharesPrice
Jun 2, 2026Warmuth Markusdirector, officer: President & CEOSell4,998$19.41
Jun 2, 2026Warmuth Markusdirector, officer: President & CEOSell468$19.73
Jun 1, 2026Townson Sharonofficer: Chief Scientific OfficerOption6,000$6.14
Jun 1, 2026Townson Sharonofficer: Chief Scientific OfficerSell6,000$19.87
May 28, 2026Champoux Jenniferofficer: Chief Operating OfficerSell2,175$20.00
May 28, 2026Champoux Jenniferofficer: Chief Operating OfficerOption2,175$3.98
May 26, 2026Champoux Jenniferofficer: Chief Operating OfficerSell2,176$19.00
May 26, 2026Champoux Jenniferofficer: Chief Operating OfficerOption2,176$3.98
May 22, 2026Manning Anthony M.directorOption10,000$4.16
May 22, 2026Manning Anthony M.directorSell10,000$18.01
May 5, 2026Warmuth Markusdirector, officer: President & CEOSell5,467$18.92
Apr 15, 2026Warmuth Markusdirector, officer: President & CEOSell8,000$17.64
Apr 10, 2026Nickson Philipofficer: Chief Business & Legal OfficerSell5,845$17.69
Apr 7, 2026Bowen Matthewofficer: Principal Accounting OfficerGrant4,300
Apr 7, 2026Bowen Matthewofficer: Principal Accounting OfficerGrant19,500$16.93
Mar 5, 2026Dunn Edmundofficer: Principal Accounting OfficerSell139$17.96
Mar 4, 2026Warmuth Markusdirector, officer: President & CEOSell5,466$17.92
Mar 2, 2026Dunn Edmundofficer: Principal Accounting OfficerOption536$13.41
Mar 2, 2026Dunn Edmundofficer: Principal Accounting OfficerSell25,164$18.10
Mar 2, 2026Dunn Edmundofficer: Principal Accounting OfficerOption25,164$13.41
Mar 2, 2026Dunn Edmundofficer: Principal Accounting OfficerSell536$17.50
Feb 24, 2026Janku Filipofficer: Chief Medical OfficerSell9,189$19.50
Jan 9, 2026Warmuth Markusdirector, officer: President & CEOSell309$24.57
Jan 9, 2026Warmuth Markusdirector, officer: President & CEOSell1,450$23.88
Jan 9, 2026Warmuth Markusdirector, officer: President & CEOSell3,707$23.24
Jan 5, 2026Champoux Jenniferofficer: Chief Operating OfficerGrant158,000$15.31
Jan 5, 2026Champoux Jenniferofficer: Chief Operating OfficerGrant35,000
Jan 5, 2026Nickson Philipofficer: Chief Business & Legal OfficerGrant126,000$15.31
Jan 5, 2026Townson Sharonofficer: Chief Scientific OfficerSell3,155$15.17
Jan 5, 2026Townson Sharonofficer: Chief Scientific OfficerGrant35,000

Source: GLUE SEC Form 4 filings, latest Jun 2, 2026. For informational purposes only — not investment advice.

Institutional activity (13F)

How institutions changed their GLUE positions over the last 6 months (SEC Form 13F).

Increased
147
New positions
92
Reduced
81
Sold out
36
Largest moves
InstitutionActionSharesFiled
NEA MANAGEMENT COMPANY, LLCUnchanged7.7MMay 15, 2026
NEA MANAGEMENT COMPANY, LLCUnchanged7.7MFeb 17, 2026
PRICE T ROWE ASSOCIATES INC /MD/Increased6.7MMay 15, 2026
BLACKROCK, INC.Increased5.6MMay 13, 2026
PRICE T ROWE ASSOCIATES INC /MD/Increased5.1MFeb 17, 2026
TCG CROSSOVER MANAGEMENT, LLCNew Position4.6MFeb 17, 2026
TCG CROSSOVER MANAGEMENT, LLCUnchanged4.6MMay 15, 2026
BVF INC/ILIncreased4.5MMay 15, 2026
VERSANT VENTURE MANAGEMENT, LLCReduced4.4MFeb 12, 2026
BAKER BROS. ADVISORS LPReduced4.3MFeb 17, 2026
BAKER BROS. ADVISORS LPUnchanged4.3MMay 15, 2026
SUVRETTA CAPITAL MANAGEMENT, LLCIncreased4.2MMay 15, 2026
BLACKROCK, INC.Increased4.2MFeb 12, 2026
BVF INC/ILReduced3.8MFeb 17, 2026
VESTAL POINT CAPITAL, LPIncreased3.6MMay 15, 2026

Source: SEC Form 13F filings. For informational purposes only — not investment advice.